Abstract
101 LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 IN STEMI VS NSTE-ACS PATIENTS: A MARKER OF CARDIOVASCULAR ATHEROSCLEROTIC RISK RATHER THAN THROMBOSIS
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have